Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10532/1955
Registro completo de metadatos
Campo DC Valor Idioma
dc.contributor.authorGrilló Dolset, María Jesús-
dc.contributor.authorBlasco Martínez, José María-
dc.contributor.authorGorvel, Jean Pierre-
dc.contributor.authorMoriyón Uria, Ignacio-
dc.contributor.authorMoreno, Edgardo-
dc.date.accessioned2012-09-03T10:33:19Z-
dc.date.available2012-09-03T10:33:19Z-
dc.date.issued2012-
dc.identifier.citationMaria-Jesus Grillo, Jose-Maria Blasco, Jean-Pierre Gorvel, Ignacio Moriyon and Edgardo Moreno. “What have we learned from brucellosis in the mouse model?” Veterinary Research 2012, 43:29, artículo nº 29-
dc.identifier.urihttp://hdl.handle.net/10532/1955-
dc.description.abstractBrucellosis is a zoonosis caused by Brucella species. Brucellosis research in natural hosts is often precluded by practical, economical and ethical reasons and mice are widely used. However, mice are not natural Brucella hosts and the course of murine brucellosis depends on bacterial strain virulence, dose and inoculation route as well as breed, genetic background, age, sex and physiological statu of mice. Therefore, meaningful experiments require a definition of these variables. Brucella spleen replication profiles are highly reproducible and course in four phases: i), onset or spleen colonization (first 48 h); ii), acute phase, from the third day to the time when bacteria reach maximal numbers; iii), chronic steady phase, where bacterial numbers plateaus; and iv), chronic declining phase, during which brucellae are eliminated. This pattern displays clear physiopathological signs and is sensitive to small virulence variations, making possible to assess attenuation when fully virulent bacteria are used as controls. Similarly, immunity studies using mice with known defects are possible. Mutations affecting INF-γ, TLR9, Myd88, Tγδ and TNF-β favor Brucella replication; whereas IL-1β, IL-18, TLR4, TLR5, TLR2, NOD1, NOD2, GM-CSF, IL/17r, Rip2, TRIF, NK or Nramp1 deficiencies have no noticeable effects. Splenomegaly development is also useful: it correlates with IFN-γ and IL-12 levels and with Brucella strain virulence. The genetic background is also important: Brucella-resistant mice (C57BL) yield lower splenic bacterial replication and less splenomegaly than susceptible breeds. When inoculum is increased, a saturating dose above which bacterial numbers per organ do not augment, is reached. Unlike many gram-negative bacteria, lethal doses are large (≥ 108 bacteria/mouse) and normally higher than the saturating dose. Persistence is a useful virulence/attenuation index and is used in vaccine (Residual Virulence) quality control. Vaccine candidates are also often tested in mice by determining splenic Brucella numbers after challenging with appropriate virulent brucellae doses at precise post-vaccination times. Since most live or killed Brucella vaccines provide some protection in mice, controls immunized with reference vaccines (S19 or Rev1) are critical. Finally, mice have been successfully used to evaluate brucellosis therapies. It is concluded that, when used properly, the mouse is a valuable brucellosis model.es_ES
dc.language.isoenes_ES
dc.subject.otherBrucelosis-
dc.subject.otherAnimales de laboratorio-
dc.subject.otherRatón-
dc.subject.otherExperimentación en laboratorio-
dc.subject.otherProducción y sanidad animales_ES
dc.titleWhat have we learned from brucellosis in the mouse model?es_ES
dc.typeArticlees_ES
dc.relation.publisherversionhttp://www.veterinaryresearch.org/content/43/1/29-
Aparece en las colecciones: [DOCIART] Artículos científicos, técnicos y divulgativos

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
2012_091.pdf2,95 MBAdobe PDFVista previa
Visualizar/Abrir


Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.

La información de este repositorio es indexada en: